Covered recipient · General Payments record
ELIZABETH SCHATZMAN
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2022
$168.63
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $156.83 | 19 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $144.81 | 18 |
| Acerta Pharma LLC | $12.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $12.02 | 05/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 915467201 | CMS |
| Novo Nordisk Inc | $1.94 | 03/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898771523 | CMS |
| Novo Nordisk Inc | $3.48 | 03/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898811270 | CMS |
| Novo Nordisk Inc | $5.19 | 03/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898771029 | CMS |
| Novo Nordisk Inc | $23.17 | 04/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898922637 | CMS |
| Novo Nordisk Inc | $1.95 | 05/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899291827 | CMS |
| Novo Nordisk Inc | $4.27 | 06/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898811279 | CMS |
| Novo Nordisk Inc | $3.67 | 06/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899432511 | CMS |
| Novo Nordisk Inc | $3.65 | 06/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898771017 | CMS |
| Novo Nordisk Inc | $11.23 | 07/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899252497 | CMS |
| Novo Nordisk Inc | $5.55 | 09/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899291835 | CMS |
| Novo Nordisk Inc | $8.76 | 09/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899432515 | CMS |
| Novo Nordisk Inc | $3.60 | 09/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898771139 | CMS |
| Novo Nordisk Inc | $12.53 | 10/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898973385 | CMS |
| Novo Nordisk Inc | $18.75 | 10/29/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898973395 | CMS |
| Novo Nordisk Inc | $16.18 | 11/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898922629 | CMS |
| Novo Nordisk Inc | $4.45 | 11/29/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899347057 | CMS |
| Novo Nordisk Inc | $7.64 | 12/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899385939 | CMS |
| Novo Nordisk Inc | $8.80 | 12/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898811287 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022
- Source files
- Dataset page · Bulk file · PY2021 , PY2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.